MENU

XRTX XORTX Therapeutics Inc. Forecast, Technical & Fundamental Analysis

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease... Show more

XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
XRTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
3710 - 33rd Street NW
Phone
+1 403 455-7727
Employees
17
Web
https://www.xortx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLDE23.631.32
+5.92%
Slide Insurance Holdings Inc
PTC146.476.17
+4.40%
PTC
ETD21.160.25
+1.20%
Ethan Allen Interiors
MBOT1.20N/A
N/A
Microbot Medical
TGL1.37-0.06
-4.53%
Treasure Global Inc.

XRTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, XRTX has been loosely correlated with BCDA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if XRTX jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XRTX
1D Price
Change %
XRTX100%
+2.37%
BCDA - XRTX
43%
Loosely correlated
+0.99%
KPRX - XRTX
30%
Poorly correlated
+0.78%
BYSI - XRTX
26%
Poorly correlated
+5.68%
CLNN - XRTX
26%
Poorly correlated
-1.47%
MIST - XRTX
26%
Poorly correlated
-5.78%
More
XORTX Therapeutics (XRTX) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com